266 related articles for article (PubMed ID: 29415055)
21. Cancer-associated fibroblasts promote non-small cell lung cancer cell invasion by upregulation of glucose-regulated protein 78 (GRP78) expression in an integrated bionic microfluidic device.
Yu T; Guo Z; Fan H; Song J; Liu Y; Gao Z; Wang Q
Oncotarget; 2016 May; 7(18):25593-603. PubMed ID: 27016417
[TBL] [Abstract][Full Text] [Related]
22. Expression of cancer-associated fibroblast-related proteins differs between invasive lobular carcinoma and invasive ductal carcinoma.
Park CK; Jung WH; Koo JS
Breast Cancer Res Treat; 2016 Aug; 159(1):55-69. PubMed ID: 27469595
[TBL] [Abstract][Full Text] [Related]
23. Human lung cancer-associated fibroblasts enhance motility of non-small cell lung cancer cells in co-culture.
Kim SH; Choe C; Shin YS; Jeon MJ; Choi SJ; Lee J; Bae GY; Cha HJ; Kim J
Anticancer Res; 2013 May; 33(5):2001-9. PubMed ID: 23645749
[TBL] [Abstract][Full Text] [Related]
24. CD45RO(+) Memory T Lymphocytes--a Candidate Marker for TNM-Immunoscore in Squamous Non-Small Cell Lung Cancer.
Paulsen EE; Kilvaer T; Khanehkenari MR; Maurseth RJ; Al-Saad S; Hald SM; Al-Shibli K; Andersen S; Richardsen E; Busund LT; Bremnes R; Donnem T
Neoplasia; 2015 Nov; 17(11):839-48. PubMed ID: 26678911
[TBL] [Abstract][Full Text] [Related]
25. Prognostic relevance of cancer-associated fibroblasts in human cancer.
Paulsson J; Micke P
Semin Cancer Biol; 2014 Apr; 25():61-8. PubMed ID: 24560651
[TBL] [Abstract][Full Text] [Related]
26. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
[TBL] [Abstract][Full Text] [Related]
27. Correlation of metabolic information on FDG-PET with tissue expression of immune markers in patients with non-small cell lung cancer (NSCLC) who are candidates for upfront surgery.
Lopci E; Toschi L; Grizzi F; Rahal D; Olivari L; Castino GF; Marchetti S; Cortese N; Qehajaj D; Pistillo D; Alloisio M; Roncalli M; Allavena P; Santoro A; Marchesi F; Chiti A
Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1954-61. PubMed ID: 27251642
[TBL] [Abstract][Full Text] [Related]
28. Tumor-stromal interactions with direct cell contacts enhance motility of non-small cell lung cancer cells through the hedgehog signaling pathway.
Choe C; Shin YS; Kim SH; Jeon MJ; Choi SJ; Lee J; Kim J
Anticancer Res; 2013 Sep; 33(9):3715-23. PubMed ID: 24023301
[TBL] [Abstract][Full Text] [Related]
29. Clinicopathological significance of caveolin-1 expression by cancer-associated fibroblasts in lung adenocarcinoma.
Shimizu K; Kirita K; Aokage K; Kojima M; Hishida T; Kuwata T; Fujii S; Ochiai A; Funai K; Yoshida J; Tsuboi M; Ishii G
J Cancer Res Clin Oncol; 2017 Feb; 143(2):321-328. PubMed ID: 27771795
[TBL] [Abstract][Full Text] [Related]
30. IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling.
Shintani Y; Fujiwara A; Kimura T; Kawamura T; Funaki S; Minami M; Okumura M
J Thorac Oncol; 2016 Sep; 11(9):1482-92. PubMed ID: 27287412
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of platelet-derived growth factors in non-small cell lung cancer tumor and stromal cells.
Donnem T; Al-Saad S; Al-Shibli K; Andersen S; Busund LT; Bremnes RM
J Thorac Oncol; 2008 Sep; 3(9):963-70. PubMed ID: 18758297
[TBL] [Abstract][Full Text] [Related]
32. MiRNA-200a expression is inverse correlation with hepatocyte growth factor expression in stromal fibroblasts and its high expression predicts a good prognosis in patients with non-small cell lung cancer.
Chen Y; Du M; Wang J; Xing P; Zhang Y; Li F; Lu X
Oncotarget; 2016 Jul; 7(30):48432-48442. PubMed ID: 27374174
[TBL] [Abstract][Full Text] [Related]
33. Cancer-associated fibroblasts drive CXCL13 production in activated T cells via TGF-beta.
O'Connor RA; Martinez BR; Koppensteiner L; Mathieson L; Akram AR
Front Immunol; 2023; 14():1221532. PubMed ID: 37520560
[TBL] [Abstract][Full Text] [Related]
34. Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer.
Kawai O; Ishii G; Kubota K; Murata Y; Naito Y; Mizuno T; Aokage K; Saijo N; Nishiwaki Y; Gemma A; Kudoh S; Ochiai A
Cancer; 2008 Sep; 113(6):1387-95. PubMed ID: 18671239
[TBL] [Abstract][Full Text] [Related]
35. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
Woo EY; Chu CS; Goletz TJ; Schlienger K; Yeh H; Coukos G; Rubin SC; Kaiser LR; June CH
Cancer Res; 2001 Jun; 61(12):4766-72. PubMed ID: 11406550
[TBL] [Abstract][Full Text] [Related]
36. The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma.
Al-Shibli K; Al-Saad S; Donnem T; Persson M; Bremnes RM; Busund LT
Histopathology; 2009 Sep; 55(3):301-12. PubMed ID: 19723145
[TBL] [Abstract][Full Text] [Related]
37. Stromal CD4/CD25 positive T-cells are a strong and independent prognostic factor in non-small cell lung cancer patients, especially with adenocarcinomas.
Kayser G; Schulte-Uentrop L; Sienel W; Werner M; Fisch P; Passlick B; Zur Hausen A; Stremmel C
Lung Cancer; 2012 Jun; 76(3):445-51. PubMed ID: 22300751
[TBL] [Abstract][Full Text] [Related]
38. Prognostic potential of FOXP3 expression in non-small cell lung cancer cells combined with tumor-infiltrating regulatory T cells.
Tao H; Mimura Y; Aoe K; Kobayashi S; Yamamoto H; Matsuda E; Okabe K; Matsumoto T; Sugi K; Ueoka H
Lung Cancer; 2012 Jan; 75(1):95-101. PubMed ID: 21719142
[TBL] [Abstract][Full Text] [Related]
39. Prognostic impact of fibroblast growth factor 2 in non-small cell lung cancer: coexpression with VEGFR-3 and PDGF-B predicts poor survival.
Donnem T; Al-Shibli K; Al-Saad S; Busund LT; Bremnes RM
J Thorac Oncol; 2009 May; 4(5):578-85. PubMed ID: 19318994
[TBL] [Abstract][Full Text] [Related]
40. Stromal FAP is an independent poor prognosis marker in non-small cell lung adenocarcinoma and associated with p53 mutation.
Moreno-Ruiz P; Corvigno S; Te Grootenhuis NC; La Fleur L; Backman M; Strell C; Mezheyeuski A; Hoelzlwimmer G; Klein C; Botling J; Micke P; Östman A
Lung Cancer; 2021 May; 155():10-19. PubMed ID: 33706022
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]